NEW YORK (GenomeWeb News) – The National Cancer Institute today said that it has released a dataset of proteins and phosphopeptides identified by researchers using deep proteomic and phosphoproteomic methods to analyze breast cancer samples.

The dataset was generated by NCI's Clinical Proteomic Tumor Analysis Consortium, which included researchers from the Broad Institute, Fred Hutchinson Cancer Research Center, and Washington University of St. Louis. The investigators used iTRAQ protein quantification methods to develop the dataset of from 105 breast cancer samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.